20 states, U.S. take aim at collusion claims, soaring prices for generic drugs

If there ever were nave wishes that parts of Big Pharma might work in more enlightened ways for patients, the attorney generals in 20 states and federal prosecutors, have dashed optimism about “white hat” drug makers. Led by Connecticut’s chief legal officer, the attorney generals have sued a half dozen makers of generic drugs, asserting they engaged in illegal price-fixing to gouge consumers.